GLP-1 receptor agonists act on the pancreas by enhancing insulin secretion, inhibiting glucagon release (see #4 below), and there is some evidence to suggest that they protect the beta cells from damage
At that point, many users shift to lower maintenance doses to keep their preferred tone
We're talking about maybe 50% absorption on a good day
Du T, Zhang H, Ruan J, Jiang H, Chen HY, Wang X
While some insurance plans do cover GLP-1s for diabetes management, coverage for weight loss indications is still limited
Tune in to learn how you can be your own best health advocate during this transformative chapter of life